(jpg, 45 KB) Infection (light zone) in the brain of multiple sclerosis patients suffering from progressive multifocal leukoencephalopathy (PML). (Image: Neuroradiology, USZ).
Researchers from the University of Zurich and the University Hospital Zurich reveal possible new treatment methods for a rare, usually fatal brain disease. Thanks to their discovery that specific antibodies play a key role in combating the viral infection, a vaccine against the disease «progressive multifocal leukoencephalopathy» could now be developed. Humans carry a multitude of viruses and bacteria in their gut, on their skin and in other organs. Often, these are involved in important bodily functions. Under certain conditions, however, some can also cause diseases. The JC virus, a member of the polyoma tumor virus family, is a prime example. This pathogen was first isolated from the brain of a patient who was suffering from a rare brain disease known as progressive multifocal leukoencephalopathy (PML).
PER LEGGERE QUESTO ARTICOLO, CREA IL TUO ACCOUNT
Ed estendere la vostra lettura, gratuitamente e senza alcun impegno.